Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotic Lozenges for Recurrent Aphthous Stomatitis
NCT04383236Completed
- Start
- Dec 2016
- Primary completion
- Oct 2018
- Modality
- Live Biotherapeutic Products
01
Overview
Randomised, open-label trial of lactobacillus acidophilus in recurrent aphthous stomatitis (RAS) (2 arms). Primary endpoints: Ulcer size reduction at 5 days and Ulcer pain moderation at 5 days. Started Dec 2016; status: completed.
02
Drugs
lactobacillus acidophilus
03
Conditions
recurrent aphthous stomatitis (RAS)
Beyond the preview
Go deeper on NCT04383236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04383236.